25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Mangalam Drugs And Organics Limited
Buy, Hold or Sell?

Let's analyze Mangalam Drugs And Organics Limited together

I guess you are interested in Mangalam Drugs And Organics Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mangalam Drugs And Organics Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Mangalam Drugs And Organics Limited

I send you an email if I find something interesting about Mangalam Drugs And Organics Limited.

1. Quick Overview

1.1. Quick analysis of Mangalam Drugs And Organics Limited (30 sec.)










1.2. What can you expect buying and holding a share of Mangalam Drugs And Organics Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
INR85.79
Expected worth in 1 year
INR44.95
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
INR-40.85
Return On Investment
-36.2%

For what price can you sell your share?

Current Price per Share
INR112.75
Expected price per share
INR101.20 - INR140.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Mangalam Drugs And Organics Limited (5 min.)




Live pricePrice per Share (EOD)
INR112.75
Intrinsic Value Per Share
INR-92.01 - INR-1.53
Total Value Per Share
INR-6.22 - INR84.26

2.2. Growth of Mangalam Drugs And Organics Limited (5 min.)




Is Mangalam Drugs And Organics Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$16.1m$18m-$1.9m-11.9%

How much money is Mangalam Drugs And Organics Limited making?

Current yearPrevious yearGrowGrow %
Making money-$1m$151.1k-$1.2m-114.0%
Net Profit Margin-2.5%0.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Mangalam Drugs And Organics Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Mangalam Drugs And Organics Limited?

Welcome investor! Mangalam Drugs And Organics Limited's management wants to use your money to grow the business. In return you get a share of Mangalam Drugs And Organics Limited.

First you should know what it really means to hold a share of Mangalam Drugs And Organics Limited. And how you can make/lose money.

Speculation

The Price per Share of Mangalam Drugs And Organics Limited is INR112.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mangalam Drugs And Organics Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mangalam Drugs And Organics Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR85.79. Based on the TTM, the Book Value Change Per Share is INR-10.21 per quarter. Based on the YOY, the Book Value Change Per Share is INR0.88 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mangalam Drugs And Organics Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.07-0.1%-0.07-0.1%0.130.1%0.100.1%0.060.1%
Usd Book Value Change Per Share-0.12-0.1%-0.12-0.1%0.010.0%0.060.1%0.080.1%
Usd Dividend Per Share0.000.0%0.000.0%0.030.0%0.020.0%0.020.0%
Usd Total Gains Per Share-0.12-0.1%-0.12-0.1%0.040.0%0.080.1%0.100.1%
Usd Price Per Share1.10-1.10-1.17-1.01-1.27-
Price to Earnings Ratio-16.07--16.07-9.06-2.55-1.34-
Price-to-Total Gains Ratio-9.02--9.02-28.10-7.24-6.36-
Price to Book Ratio1.07-1.07-1.02-0.97-1.88-
Price-to-Total Gains Ratio-9.02--9.02-28.10-7.24-6.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.341725
Number of shares745
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.120.06
Usd Total Gains Per Share-0.120.08
Gains per Quarter (745 shares)-90.5358.75
Gains per Year (745 shares)-362.12234.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-362-37256179225
20-724-734111359460
30-1086-1096167538695
40-1448-1458222718930
50-1811-18202788971165
60-2173-218233410761400
70-2535-254438912561635
80-2897-290644514351870
90-3259-326850016152105
100-3621-363055617942340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%12.05.00.070.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%12.05.00.070.6%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%9.00.08.052.9%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%12.05.00.070.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Mangalam Drugs And Organics Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---10.212-10.2120%0.881-1259%5.059-302%7.112-244%
Book Value Per Share--85.79285.7920%96.003-11%85.065+1%66.413+29%
Current Ratio--1.0731.0730%1.249-14%1.208-11%1.228-13%
Debt To Asset Ratio--0.5930.5930%0.577+3%0.553+7%0.585+1%
Debt To Equity Ratio--1.4551.4550%1.367+6%1.246+17%1.626-10%
Dividend Per Share----0%2.606-100%1.568-100%1.443-100%
Eps---5.731-5.7310%10.818-153%8.078-171%5.228-210%
Free Cash Flow Per Share---5.004-5.0040%7.335-168%2.711-285%4.171-220%
Free Cash Flow To Equity Per Share---1.702-1.7020%-3.164+86%-0.977-43%-0.429-75%
Gross Profit Margin--1.1421.1420%-3.875+439%-0.187+116%0.299+281%
Intrinsic Value_10Y_max---1.533--------
Intrinsic Value_10Y_min---92.008--------
Intrinsic Value_1Y_max--3.246--------
Intrinsic Value_1Y_min---2.073--------
Intrinsic Value_3Y_max--7.162--------
Intrinsic Value_3Y_min---12.456--------
Intrinsic Value_5Y_max--7.955--------
Intrinsic Value_5Y_min---29.583--------
Market Cap1784629550.000+18%1457781640.8001457781640.8000%1551168304.000-6%1339386345.760+9%1685627927.720-14%
Net Profit Margin---0.025-0.0250%0.003-817%0.025-198%0.032-176%
Operating Margin--0.0070.0070%0.040-82%0.058-87%0.073-90%
Operating Ratio--0.9930.9930%0.961+3%0.941+6%0.921+8%
Pb Ratio1.314+18%1.0741.0740%1.021+5%0.969+11%1.880-43%
Pe Ratio-19.673-22%-16.070-16.0700%9.059-277%2.548-731%1.336-1303%
Price Per Share112.750+18%92.10092.1000%98.000-6%84.620+9%106.495-14%
Price To Free Cash Flow Ratio-22.533-22%-18.406-18.4060%13.361-238%-25.298+37%3.508-625%
Price To Total Gains Ratio-11.041-22%-9.019-9.0190%28.104-132%7.243-225%6.360-242%
Quick Ratio--0.2120.2120%0.386-45%0.502-58%0.534-60%
Return On Assets---0.027-0.0270%0.004-870%0.036-176%0.048-156%
Return On Equity---0.067-0.0670%0.008-899%0.073-191%0.122-155%
Total Gains Per Share---10.212-10.2120%3.487-393%6.627-254%8.555-219%
Usd Book Value--16159378.90016159378.9000%18082787.800-11%16022431.320+1%12509304.990+29%
Usd Book Value Change Per Share---0.122-0.1220%0.010-1259%0.060-302%0.085-244%
Usd Book Value Per Share--1.0211.0210%1.142-11%1.012+1%0.790+29%
Usd Dividend Per Share----0%0.031-100%0.019-100%0.017-100%
Usd Eps---0.068-0.0680%0.129-153%0.096-171%0.062-210%
Usd Free Cash Flow---942491.900-942491.9000%1381518.600-168%510702.780-285%785647.520-220%
Usd Free Cash Flow Per Share---0.060-0.0600%0.087-168%0.032-285%0.050-220%
Usd Free Cash Flow To Equity Per Share---0.020-0.0200%-0.038+86%-0.012-43%-0.005-75%
Usd Market Cap21237091.645+18%17347601.52617347601.5260%18458902.818-6%15938697.515+9%20058972.340-14%
Usd Price Per Share1.342+18%1.0961.0960%1.166-6%1.007+9%1.267-14%
Usd Profit---1079532.300-1079532.3000%151130.000-814%1144284.960-194%1259128.290-186%
Usd Revenue--43862781.20043862781.2000%44053252.6000%43989473.3600%37682845.830+16%
Usd Total Gains Per Share---0.122-0.1220%0.041-393%0.079-254%0.102-219%
 EOD+5 -3MRQTTM+0 -0YOY+6 -305Y+8 -2810Y+10 -26

3.3 Fundamental Score

Let's check the fundamental score of Mangalam Drugs And Organics Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.673
Price to Book Ratio (EOD)Between0-11.314
Net Profit Margin (MRQ)Greater than0-0.025
Operating Margin (MRQ)Greater than00.007
Quick Ratio (MRQ)Greater than10.212
Current Ratio (MRQ)Greater than11.073
Debt to Asset Ratio (MRQ)Less than10.593
Debt to Equity Ratio (MRQ)Less than11.455
Return on Equity (MRQ)Greater than0.15-0.067
Return on Assets (MRQ)Greater than0.05-0.027
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Mangalam Drugs And Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.524
Ma 20Greater thanMa 50115.394
Ma 50Greater thanMa 100124.369
Ma 100Greater thanMa 200117.515
OpenGreater thanClose112.750
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Mangalam Drugs And Organics Limited

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; and ortho phenoxy methane sulfonanilide, tenofovir alafenamide base, and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol; bictegravir Na, aripiprazole, risperidone, olanzapine, and etodolac; and develops tafenoquine succinate and pretomanid. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. The company was incorporated in 1972 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-10-22 19:15:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Mangalam Drugs And Organics Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -2.5% means that ₹-0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mangalam Drugs And Organics Limited:

  • The MRQ is -2.5%. The company is making a loss. -1
  • The TTM is -2.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.5%TTM-2.5%0.0%
TTM-2.5%YOY0.3%-2.8%
TTM-2.5%5Y2.5%-5.0%
5Y2.5%10Y3.2%-0.7%
4.3.1.2. Return on Assets

Shows how efficient Mangalam Drugs And Organics Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.7% Return on Assets means that Mangalam Drugs And Organics Limited generated ₹-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mangalam Drugs And Organics Limited:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-2.7%0.0%
TTM-2.7%YOY0.4%-3.1%
TTM-2.7%5Y3.6%-6.3%
5Y3.6%10Y4.8%-1.3%
4.3.1.3. Return on Equity

Shows how efficient Mangalam Drugs And Organics Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.7% Return on Equity means Mangalam Drugs And Organics Limited generated ₹-0.07 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mangalam Drugs And Organics Limited:

  • The MRQ is -6.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.7%TTM-6.7%0.0%
TTM-6.7%YOY0.8%-7.5%
TTM-6.7%5Y7.3%-14.0%
5Y7.3%10Y12.2%-4.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Mangalam Drugs And Organics Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Mangalam Drugs And Organics Limited is operating .

  • Measures how much profit Mangalam Drugs And Organics Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.7% means the company generated ₹0.01  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 0.7%. The company is operating inefficient. -1
  • The TTM is 0.7%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%0.0%
TTM0.7%YOY4.0%-3.3%
TTM0.7%5Y5.8%-5.1%
5Y5.8%10Y7.3%-1.5%
4.3.2.2. Operating Ratio

Measures how efficient Mangalam Drugs And Organics Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are ₹0.99 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 0.993. The company is less efficient in keeping operating costs low.
  • The TTM is 0.993. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.993TTM0.9930.000
TTM0.993YOY0.961+0.032
TTM0.9935Y0.941+0.052
5Y0.94110Y0.921+0.019
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Mangalam Drugs And Organics Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Mangalam Drugs And Organics Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.07 means the company has ₹1.07 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 1.073. The company is just able to pay all its short-term debts.
  • The TTM is 1.073. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.073TTM1.0730.000
TTM1.073YOY1.249-0.176
TTM1.0735Y1.208-0.135
5Y1.20810Y1.228-0.020
4.4.3.2. Quick Ratio

Measures if Mangalam Drugs And Organics Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.21 means the company can pay off ₹0.21 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 0.212. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.212. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.212TTM0.2120.000
TTM0.212YOY0.386-0.174
TTM0.2125Y0.502-0.290
5Y0.50210Y0.534-0.032
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Mangalam Drugs And Organics Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Mangalam Drugs And Organics Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mangalam Drugs And Organics Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.59 means that Mangalam Drugs And Organics Limited assets are financed with 59.3% credit (debt) and the remaining percentage (100% - 59.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 0.593. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.593. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.593TTM0.5930.000
TTM0.593YOY0.577+0.015
TTM0.5935Y0.553+0.040
5Y0.55310Y0.585-0.032
4.5.4.2. Debt to Equity Ratio

Measures if Mangalam Drugs And Organics Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 145.5% means that company has ₹1.46 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mangalam Drugs And Organics Limited:

  • The MRQ is 1.455. The company is able to pay all its debts with equity. +1
  • The TTM is 1.455. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.455TTM1.4550.000
TTM1.455YOY1.367+0.089
TTM1.4555Y1.246+0.209
5Y1.24610Y1.626-0.380
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Mangalam Drugs And Organics Limited generates.

  • Above 15 is considered overpriced but always compare Mangalam Drugs And Organics Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -16.07 means the investor is paying ₹-16.07 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mangalam Drugs And Organics Limited:

  • The EOD is -19.673. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.070. Based on the earnings, the company is expensive. -2
  • The TTM is -16.070. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.673MRQ-16.070-3.603
MRQ-16.070TTM-16.0700.000
TTM-16.070YOY9.059-25.129
TTM-16.0705Y2.548-18.618
5Y2.54810Y1.336+1.212
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mangalam Drugs And Organics Limited:

  • The EOD is -22.533. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.406. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.406. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.533MRQ-18.406-4.127
MRQ-18.406TTM-18.4060.000
TTM-18.406YOY13.361-31.767
TTM-18.4065Y-25.298+6.892
5Y-25.29810Y3.508-28.807
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Mangalam Drugs And Organics Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.07 means the investor is paying ₹1.07 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Mangalam Drugs And Organics Limited:

  • The EOD is 1.314. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.074. Based on the equity, the company is underpriced. +1
  • The TTM is 1.074. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.314MRQ1.074+0.241
MRQ1.074TTM1.0740.000
TTM1.074YOY1.021+0.053
TTM1.0745Y0.969+0.105
5Y0.96910Y1.880-0.911
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Other Stockholders Equity  1,004,027-780,274223,7534,265228,018-4,265223,753-1,199,646-975,893
Long-term Assets Other  25,8531,00126,854-2,74324,111-15,3078,804-8,826-22
Income before Tax  62,521332,670395,191-117,861277,330-255,19222,138-132,870-110,732
Net Income  82,525197,184279,709-83,134196,575-183,87512,700-103,417-90,717
Tax Provision  412,383-296,901115,482298,359413,841-404,4039,438-29,453-20,015
Net Income from Continuing Operations  82,525197,184279,709-83,134196,575-183,87512,700-103,417-90,717



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,334,242
Total Liabilities1,976,311
Total Stockholder Equity1,357,930
 As reported
Total Liabilities 1,976,311
Total Stockholder Equity+ 1,357,930
Total Assets = 3,334,242

Assets

Total Assets3,334,242
Total Current Assets1,757,243
Long-term Assets1,576,999
Total Current Assets
Cash And Cash Equivalents 9,114
Short-term Investments 47,331
Net Receivables 291,096
Inventory 1,236,398
Other Current Assets 220,635
Total Current Assets  (as reported)1,757,243
Total Current Assets  (calculated)1,804,574
+/- 47,331
Long-term Assets
Property Plant Equipment 1,268,867
Intangible Assets 285,182
Long-term Assets  (as reported)1,576,999
Long-term Assets  (calculated)1,554,049
+/- 22,950

Liabilities & Shareholders' Equity

Total Current Liabilities1,637,853
Long-term Liabilities338,458
Total Stockholder Equity1,357,930
Total Current Liabilities
Short-term Debt 800,046
Short Long Term Debt 745,958
Accounts payable 658,862
Other Current Liabilities 132,335
Total Current Liabilities  (as reported)1,637,853
Total Current Liabilities  (calculated)2,337,201
+/- 699,348
Long-term Liabilities
Long term Debt 133,541
Capital Lease Obligations 105,426
Long-term Liabilities Other 32,716
Long-term Liabilities  (as reported)338,458
Long-term Liabilities  (calculated)271,683
+/- 66,775
Total Stockholder Equity
Common Stock158,282
Retained Earnings 975,893
Accumulated Other Comprehensive Income 1,199,648
Other Stockholders Equity -975,893
Total Stockholder Equity (as reported)1,357,930
Total Stockholder Equity (calculated)1,357,930
+/-0
Other
Capital Stock158,282
Cash and Short Term Investments 9,114
Common Stock Shares Outstanding 15,828
Current Deferred Revenue46,610
Liabilities and Stockholders Equity 3,334,242
Net Debt 975,811
Net Invested Capital 2,237,429
Net Working Capital 119,390
Property Plant and Equipment Gross 1,290,845
Short Long Term Debt Total 984,925



6.3. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
776,604
893,847
956,883
1,132,517
1,219,454
1,147,775
1,254,443
1,698,950
1,597,639
1,910,373
2,360,139
2,091,261
2,306,671
2,628,477
3,284,257
3,596,288
3,334,242
3,334,2423,596,2883,284,2572,628,4772,306,6712,091,2612,360,1391,910,3731,597,6391,698,9501,254,4431,147,7751,219,4541,132,517956,883893,847776,604
   > Total Current Assets 
415,048
454,602
490,201
586,418
628,496
574,335
696,623
1,160,369
996,538
973,184
1,323,083
1,050,397
1,191,747
1,319,771
1,824,656
2,065,841
1,757,243
1,757,2432,065,8411,824,6561,319,7711,191,7471,050,3971,323,083973,184996,5381,160,369696,623574,335628,496586,418490,201454,602415,048
       Cash And Cash Equivalents 
9,302
7,019
6,473
6,924
10,268
879
1,023
6,794
4,953
6,273
4,304
14,334
16,291
5,917
19,469
26,807
9,114
9,11426,80719,4695,91716,29114,3344,3046,2734,9536,7941,02387910,2686,9246,4737,0199,302
       Short-term Investments 
0
0
0
0
1,444
1,844
1,792
2,402
2,401
2,439
16,561
164,688
303,194
76
76
73,067
47,331
47,33173,0677676303,194164,68816,5612,4392,4012,4021,7921,8441,4440000
       Net Receivables 
0
0
0
0
0
238,706
296,873
442,469
346,980
562,637
602,370
283,660
509,286
710,334
616,691
465,784
291,096
291,096465,784616,691710,334509,286283,660602,370562,637346,980442,469296,873238,70600000
       Inventory 
172,844
177,024
238,617
332,706
489,846
310,596
364,776
573,404
473,406
372,495
679,447
734,532
648,427
585,875
1,171,055
1,374,665
1,236,398
1,236,3981,374,6651,171,055585,875648,427734,532679,447372,495473,406573,404364,776310,596489,846332,706238,617177,024172,844
       Other Current Assets 
232,902
270,559
245,111
246,788
126,938
261,016
329,032
577,769
515,778
591,977
20,401
17,871
17,743
17,645
17,365
125,518
220,635
220,635125,51817,36517,64517,74317,87120,401591,977515,778577,769329,032261,016126,938246,788245,111270,559232,902
   > Long-term Assets 
361,556
439,245
466,682
546,099
590,958
573,440
557,820
538,581
601,101
937,189
1,037,058
1,040,864
1,114,923
1,308,706
1,459,602
1,530,447
1,576,999
1,576,9991,530,4471,459,6021,308,7061,114,9231,040,8641,037,058937,189601,101538,581557,820573,440590,958546,099466,682439,245361,556
       Property Plant Equipment 
355,333
435,439
465,242
544,659
569,878
551,336
533,843
529,479
591,170
925,564
1,012,274
1,015,774
1,027,712
1,197,113
1,292,059
1,335,525
1,268,867
1,268,8671,335,5251,292,0591,197,1131,027,7121,015,7741,012,274925,564591,170529,479533,843551,336569,878544,659465,242435,439355,333
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
2,401
2,401
0
0
0
0
0
000002,4012,4010000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
96,048
106,380
7,531
4,852
61,358
84,739
138,763
182,991
285,182
285,182182,991138,76384,73961,3584,8527,531106,38096,04800000000
       Long-term Assets Other 
6,223
3,806
1,440
1,440
21,080
22,104
23,977
9,102
9,931
11,625
17,253
20,238
25,853
26,854
24,111
8,804
-22
-228,80424,11126,85425,85320,23817,25311,6259,9319,10223,97722,10421,0801,4401,4403,8066,223
> Total Liabilities 
395,795
500,354
545,160
696,555
838,837
885,154
1,022,214
1,405,309
982,396
1,048,736
1,308,315
1,133,699
1,267,283
1,318,858
1,778,643
2,076,726
1,976,311
1,976,3112,076,7261,778,6431,318,8581,267,2831,133,6991,308,3151,048,736982,3961,405,3091,022,214885,154838,837696,555545,160500,354395,795
   > Total Current Liabilities 
108,547
135,829
142,872
183,944
554,749
428,274
614,337
994,625
728,692
739,846
1,076,552
904,417
1,094,669
1,076,408
1,301,134
1,653,574
1,637,853
1,637,8531,653,5741,301,1341,076,4081,094,669904,4171,076,552739,846728,692994,625614,337428,274554,749183,944142,872135,829108,547
       Short-term Debt 
0
0
0
0
340,451
286,627
313,667
318,243
353,757
380,672
577,827
543,013
470,002
596,404
575,874
567,820
800,046
800,046567,820575,874596,404470,002543,013577,827380,672353,757318,243313,667286,627340,4510000
       Short Long Term Debt 
0
0
0
0
0
0
771,801
66,974
75,238
380,672
577,827
543,013
458,648
511,816
470,962
495,671
745,958
745,958495,671470,962511,816458,648543,013577,827380,67275,23866,974771,801000000
       Accounts payable 
0
0
0
0
126,844
106,977
208,673
547,729
206,750
207,755
376,251
324,135
565,934
426,787
545,471
970,727
658,862
658,862970,727545,471426,787565,934324,135376,251207,755206,750547,729208,673106,977126,8440000
       Other Current Liabilities 
108,547
135,829
142,872
183,944
87,454
34,670
91,997
128,653
168,185
124,184
88,831
2,878
18,817
17,562
13,884
35,234
132,335
132,33535,23413,88417,56218,8172,87888,831124,184168,185128,65391,99734,67087,454183,944142,872135,829108,547
   > Long-term Liabilities 
287,248
364,525
402,288
512,611
284,088
456,880
407,877
410,684
253,704
308,890
231,763
229,282
172,614
242,450
477,509
423,152
338,458
338,458423,152477,509242,450172,614229,282231,763308,890253,704410,684407,877456,880284,088512,611402,288364,525287,248
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,805,245
2,280,003
1,885,488
2,917,885
3,493,955
4,173,412
3,663,483
2,986,417
0
02,986,4173,663,4834,173,4123,493,9552,917,8851,885,4882,280,0032,805,24500000000
       Other Liabilities 
0
0
0
0
0
0
5,856
16,980
84,489
91,760
120,298
143,325
122,880
141,791
174,340
168,097
0
0168,097174,340141,791122,880143,325120,29891,76084,48916,9805,856000000
> Total Stockholder Equity
380,809
393,493
411,723
435,962
380,617
262,621
232,229
293,641
615,243
861,637
1,051,824
957,562
1,039,388
1,309,619
1,505,614
1,519,562
1,357,930
1,357,9301,519,5621,505,6141,309,6191,039,388957,5621,051,824861,637615,243293,641232,229262,621380,617435,962411,723393,493380,809
   Common Stock
131,782
131,782
131,782
131,782
131,782
131,782
131,782
131,782
143,782
158,282
158,282
158,282
158,282
158,282
158,282
158,282
158,282
158,282158,282158,282158,282158,282158,282158,282158,282143,782131,782131,782131,782131,782131,782131,782131,782131,782
   Retained Earnings 
14,261
22,794
35,706
56,590
62,927
-55,069
-85,461
-24,049
134,728
371,697
561,884
467,622
549,448
825,123
1,015,674
1,029,622
975,893
975,8931,029,6221,015,674825,123549,448467,622561,884371,697134,728-24,049-85,461-55,06962,92756,59035,70622,79414,261
   Accumulated Other Comprehensive Income 
-148,852
-174,693
-203,048
-234,396
-270,893
-309,958
-348,909
-388,758
-433,782
-477,046
-539,207
-606,150
-672,369
102,461
103,640
107,905
1,199,648
1,199,648107,905103,640102,461-672,369-606,150-539,207-477,046-433,782-388,758-348,909-309,958-270,893-234,396-203,048-174,693-148,852
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
180,575
180,575
180,575
0
0180,575180,575180,5750000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
383,618
413,610
447,283
481,986
456,801
495,866
534,817
574,666
770,515
808,704
870,865
937,808
1,004,027
223,753
228,018
223,753
-975,893
-975,893223,753228,018223,7531,004,027937,808870,865808,704770,515574,666534,817495,866456,801481,986447,283413,610383,618



6.4. Balance Sheets

Currency in INR. All numbers in thousands.




6.5. Cash Flows

Currency in INR. All numbers in thousands.




6.6. Income Statements

Currency in INR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,685,948
Cost of Revenue-2,982,343
Gross Profit703,605703,605
 
Operating Income (+$)
Gross Profit703,605
Operating Expense-676,147
Operating Income27,45827,458
 
Operating Expense (+$)
Research Development32,703
Selling General Administrative390,713
Selling And Marketing Expenses12,847
Operating Expense676,147436,263
 
Net Interest Income (+$)
Interest Income0
Interest Expense-139,170
Other Finance Cost-0
Net Interest Income-139,170
 
Pretax Income (+$)
Operating Income27,458
Net Interest Income-139,170
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-110,732165,648
EBIT - interestExpense = -111,712
-110,732
48,453
Interest Expense139,170
Earnings Before Interest and Taxes (EBIT)27,45828,438
Earnings Before Interest and Taxes (EBITDA)173,966
 
After tax Income (+$)
Income Before Tax-110,732
Tax Provision--20,015
Net Income From Continuing Ops-90,717-90,717
Net Income-90,717
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,658,490
Total Other Income/Expenses Net-138,190139,170
 

Technical Analysis of Mangalam Drugs And Organics Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mangalam Drugs And Organics Limited. The general trend of Mangalam Drugs And Organics Limited is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mangalam Drugs And Organics Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mangalam Drugs And Organics Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 113.15 < 125.95 < 140.50.

The bearish price targets are: 103.00 > 103.00 > 101.20.

Tweet this
Mangalam Drugs And Organics Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mangalam Drugs And Organics Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mangalam Drugs And Organics Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mangalam Drugs And Organics Limited. The current macd is -3.82742687.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mangalam Drugs And Organics Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mangalam Drugs And Organics Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mangalam Drugs And Organics Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mangalam Drugs And Organics Limited Daily Moving Average Convergence/Divergence (MACD) ChartMangalam Drugs And Organics Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mangalam Drugs And Organics Limited. The current adx is 25.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mangalam Drugs And Organics Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Mangalam Drugs And Organics Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mangalam Drugs And Organics Limited. The current sar is 113.71.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Mangalam Drugs And Organics Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mangalam Drugs And Organics Limited. The current rsi is 42.52. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Mangalam Drugs And Organics Limited Daily Relative Strength Index (RSI) ChartMangalam Drugs And Organics Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mangalam Drugs And Organics Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mangalam Drugs And Organics Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Mangalam Drugs And Organics Limited Daily Stochastic Oscillator ChartMangalam Drugs And Organics Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mangalam Drugs And Organics Limited. The current cci is -41.63464658.

Mangalam Drugs And Organics Limited Daily Commodity Channel Index (CCI) ChartMangalam Drugs And Organics Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mangalam Drugs And Organics Limited. The current cmo is -9.77715699.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Mangalam Drugs And Organics Limited Daily Chande Momentum Oscillator (CMO) ChartMangalam Drugs And Organics Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mangalam Drugs And Organics Limited. The current willr is -53.01204819.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mangalam Drugs And Organics Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Mangalam Drugs And Organics Limited Daily Williams %R ChartMangalam Drugs And Organics Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mangalam Drugs And Organics Limited.

Mangalam Drugs And Organics Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mangalam Drugs And Organics Limited. The current atr is 4.65001351.

Mangalam Drugs And Organics Limited Daily Average True Range (ATR) ChartMangalam Drugs And Organics Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mangalam Drugs And Organics Limited. The current obv is 7,307,621.

Mangalam Drugs And Organics Limited Daily On-Balance Volume (OBV) ChartMangalam Drugs And Organics Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mangalam Drugs And Organics Limited. The current mfi is 27.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Mangalam Drugs And Organics Limited Daily Money Flow Index (MFI) ChartMangalam Drugs And Organics Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mangalam Drugs And Organics Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Mangalam Drugs And Organics Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mangalam Drugs And Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.524
Ma 20Greater thanMa 50115.394
Ma 50Greater thanMa 100124.369
Ma 100Greater thanMa 200117.515
OpenGreater thanClose112.750
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Mangalam Drugs And Organics Limited with someone you think should read this too:
  • Are you bullish or bearish on Mangalam Drugs And Organics Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mangalam Drugs And Organics Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mangalam Drugs And Organics Limited

I send you an email if I find something interesting about Mangalam Drugs And Organics Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Mangalam Drugs And Organics Limited.

Receive notifications about Mangalam Drugs And Organics Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.